126 related articles for article (PubMed ID: 38213180)
1. Expression and Clinical Significance of CD30 and CD56 in Lymphoblastic Lymphoma: A Retrospective Analysis on Paraffin-Embedded Tissues by Immunohistochemistry.
Li S; Zheng S; Huang X; Zhang W; Liu F; Cao Q
Fetal Pediatr Pathol; 2024; 43(2):111-122. PubMed ID: 38213180
[No Abstract] [Full Text] [Related]
2. Using oligonucleotide aptamer probes for immunostaining of formalin-fixed and paraffin-embedded tissues.
Zeng Z; Zhang P; Zhao N; Sheehan AM; Tung CH; Chang CC; Zu Y
Mod Pathol; 2010 Dec; 23(12):1553-8. PubMed ID: 20693984
[TBL] [Abstract][Full Text] [Related]
3. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
4. Ber-H2 (CD30) immunohistochemical staining in malignant melanoma.
Polski JM; Janney CG
Mod Pathol; 1999 Sep; 12(9):903-6. PubMed ID: 10496599
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.
Khurana S; Heckman MG; Craig FE; Cochuyt JJ; Greipp P; Rahman ZA; Sproat LZ; Litzow M; Foran JM; Jiang LJ
Arch Pathol Lab Med; 2024 Apr; 148(4):471-475. PubMed ID: 37522711
[TBL] [Abstract][Full Text] [Related]
6. 16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphoma.
Romaguera JE; Garcia-Foncillas J; Cabanillas F
Leuk Lymphoma; 1995 Dec; 20(1-2):97-102. PubMed ID: 8750629
[TBL] [Abstract][Full Text] [Related]
7. Better method for detection of CD30: Immunohistochemistry or flow cytometry?
Higashi M; Kikuchi J; Murakami C; Takayanagi N; Momose S; Kizaki M; Tamaru JI
J Clin Exp Hematop; 2021 Dec; 61(4):221-223. PubMed ID: 34511584
[TBL] [Abstract][Full Text] [Related]
8. [A study of LEF1 protein expression in diagnosis and differential diagnosis of lymphoblastic lymphoma/acute lymphoblastic leukemia].
Chen X; Rui WW; Bi K; Wu YJ; Zhang SX; Zhang L; Yu J; Xiu B; Yi XH; Zeng Y
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):207-212. PubMed ID: 33677883
[No Abstract] [Full Text] [Related]
9. Ber-H2 (CD30) immunohistochemical staining of human fetal tissues.
Tamiolakis D; Papadopoulos N; Lambropoulou M; Venizelos J; Verettas D; Tsikouras P; Koutsougeras G; Papadopoulos H; Karpouzis A; Kouskoukis C
Int J Biol Sci; 2005; 1(4):135-40. PubMed ID: 16244703
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinicopathologic features of CD30-positive de novo diffuse large B-cell lymphoma in Chinese patients: a retrospective study of 232 cases.
Gong QX; Lu TX; Liu C; Wang Z; Liang JH; Xu W; Li JY; Zhang ZH; Chen Q
Int J Clin Exp Pathol; 2015; 8(12):15825-35. PubMed ID: 26884853
[TBL] [Abstract][Full Text] [Related]
11. Utility of a new notation to visualize flow cytometry analysis results: first preliminary comparison with immunohistochemistry to detect CD30 expression on T-cell lymphoma cells.
Fujishima F; Fukuhara N; Katsushima H; Nakamura Y; Harigae H; Sasano H; Ichinohasama R
BMC Cancer; 2021 Dec; 21(1):1352. PubMed ID: 34930176
[TBL] [Abstract][Full Text] [Related]
12. Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas.
Tsang WY; Chan JK; Ng CS; Pau MY
Am J Surg Pathol; 1996 Feb; 20(2):202-10. PubMed ID: 8554110
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of CON6D/B5: a new CD30 monoclonal antibody.
Lau SK; Thomas P; Weiss LM
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):273-7. PubMed ID: 20090517
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features and prognostic significance of CD30 expression in
Salas MQ; Climent F; Tapia G; DomingoDomènech E; Mercadal S; Oliveira AC; Aguilera C; Olga G; Moreno Velázquez M; Andrade-Campos M; Encuentra M; Fernández de Sevilla A; Sureda A; Sancho JM; González-Barca E
Biomarkers; 2020 Feb; 25(1):69-75. PubMed ID: 31752540
[No Abstract] [Full Text] [Related]
15. Differential expression of BCL11b and CDKN2A in CD30-positive peripheral T cell lymphoma: Retrospective study.
Wang Y; Zhang F; Gao N; Bu P; Cui W; Xi Y
Medicine (Baltimore); 2023 Nov; 102(46):e35531. PubMed ID: 37986346
[TBL] [Abstract][Full Text] [Related]
16. Characteristic Distribution Pattern of CD30-positive Cytotoxic T Cells Aids Diagnosis of Kikuchi-Fujimoto Disease.
Tabata T; Takata K; Miyata-Takata T; Sato Y; Ishizawa S; Kunitomo T; Nagakita K; Ohnishi N; Taniguchi K; Noujima-Harada M; Maeda Y; Tanimoto M; Yoshino T
Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):274-282. PubMed ID: 27389558
[TBL] [Abstract][Full Text] [Related]
17. CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma.
Gong QX; Wang Z; Liu C; Li X; Lu TX; Liang JH; Xu W; Li JY; Zhang ZH
J Clin Pathol; 2018 Sep; 71(9):795-801. PubMed ID: 29666157
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.
Xi Y; Li J; Zhang P; Bai W; Gao N; Bai W; Zhang Y; Wu Y; Ning Y
Exp Mol Pathol; 2015 Oct; 99(2):297-302. PubMed ID: 26231295
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of CD10 in paraffin sections of hematopoietic neoplasms: a comparison with flow cytometry detection in 56 cases.
Chu PG; Chang KL; Weiss LM; Arber DA
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):257-62. PubMed ID: 11127916
[TBL] [Abstract][Full Text] [Related]
20. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
